Clinical Trials Browser

Has results × Myasthenia Gravis × Amifampridine × Clear all

NCT03579966 2024-05-07

Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis)

Phase 3 Terminated

63 enrolled 10 charts

Myasthenia Gravis

NCT03304054 2024-03-12

Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG

Phase 3 Completed

93 enrolled 11 charts

Myasthenia Gravis